Evidence map›Paper›PMID 30422251›Full record

ArticleJAMA2018

Association of Medicaid Expansion With 1-Year Mortality Among Patients With End-Stage Renal Disease.

Shailender Swaminathan, Benjamin D Sommers, Rebecca Thorsness, Rajnish Mehrotra, Yoojin Lee, Amal N Trivedi

Abstract read
In one paragraph

Article in JAMA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Medicaid Expansion and Optimal Starts of Treatment for Incident Kidney Failure.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  10. Patients' Perspectives on Health-Related Social Needs and Recommendations for Interventions: A Qualitative Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Shailender SwaminathanDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
Benjamin D SommersDepartment of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Rebecca ThorsnessDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
Rajnish MehrotraDepartment of Medicine, University of Washington School of Medicine, Seattle.
Yoojin LeeDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
Amal N TrivediDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.

Funding

Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 EraR01DK113298 · NIDDK · BROWN UNIVERSITY · PI TRIVEDI, AMAL N. · 2017 to 2023
$2.2M
NIDDK NIH HHS R01 DK113298
6 · The paper itself

Abstract

Importance: The Affordable Care Act Medicaid expansion may be associated with reduced mortality, but evidence to date is limited. Patients with end-stage renal disease (ESRD) are a high-risk group that may be particularly affected by Medicaid expansion. Objective: To examine the association of Medicaid expansion with 1-year mortality among nonelderly patients with ESRD initiating dialysis. Design, Setting, and Participants: Difference-in-differences analysis of nonelderly patients initiating dialysis in Medicaid expansion and nonexpansion states from January 2011 to March 2017. Exposure: Living in a Medicaid expansion state. Main Outcomes and Measures: The primary outcome was 1-year mortality. Secondary outcomes were insurance, predialysis nephrology care, and type of vascular access for hemodialysis. Results: A total of 142 724 patients in expansion states (mean age, 50.2 years; 40.2% women) and 93 522 patients in nonexpansion states (mean age, 49.7; 42.4% women) were included. In Medicaid expansion states, 1-year mortality following dialysis initiation declined from 6.9% in the preexpansion period to 6.1% after expansion (change, -0.8 percentage points; 95% CI, -1.1 to -0.5). In nonexpansion states, mortality rates were 7.0% before expansion and 6.8% after expansion (change, -0.2 percentage points; 95% CI, -0.5 to 0.2), yielding an adjusted absolute reduction in mortality in expansion states of -0.6 percentage points (95% CI, -1.0 to -0.2). Mortality reductions were largest for black patients (-1.4 percentage points; 95% CI, -2.2, -0.7; P=.04 for interaction) and patients aged 19 to 44 years (-1.1 percentage points; 95% CI, -2.1 to -0.3; P=.01 for interaction). Expansion was associated with a 10.5-percentage-point (95% CI, 7.7-13.2) increase in Medicaid coverage at dialysis initiation, a -4.2-percentage-point (95% CI, -6.0 to -2.3) decrease in being uninsured, and a 2.3-percentage-point (95% CI, 0.6-4.1) increase in the presence of an arteriovenous fistula or graft. Changes in predialysis nephrology care were not significant. Conclusions and Relevance: Among patients with ESRD initiating dialysis, living in a state that expanded Medicaid under the Affordable Care Act was associated with lower 1-year mortality. If this association is causal, further research is needed to understand what factors may have contributed to this finding.

Indexed as

Insurance CoverageMedicaidPatient Protection and Affordable Care ActAdultFemaleHumansKidney Failure, ChronicMaleMedically UninsuredMiddle AgedMortalityRenal DialysisUnited States

Identifiers

PMID30422251
PMCPMC6417808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.